Pyxis Oncology, Inc. (PYXS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.35
Day's range
$1.51

Pyxis Oncology Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PFIZER INC 02/12/2026 7.03 M $8.09 M   0.00% 11.24%
LAURION CAPITAL MANAGEMENT LP 02/17/2026 4.80 M $5.52 M   32.28% 7.67%
02/17/2026 4.12 M $4.74 M   100.00% 6.59%
VANGUARD GROUP INC 01/29/2026 2.34 M $2.69 M   7.94% 3.73%
PALO ALTO INVESTORS LP 02/17/2026 1.04 M $1.19 M   0.00% 1.66%
683 CAPITAL MANAGEMENT, LLC 02/17/2026 891.91 K $1.03 M   69.89% 1.43%
JANE STREET GROUP, LLC 02/12/2026 786.01 K $903.91 K   158.81% 1.26%
BLACKROCK, INC. 02/12/2026 784.08 K $901.69 K   14.68% 1.25%
MILLENNIUM MANAGEMENT LLC 02/17/2026 743.11 K $854.57 K   -8.86% 1.19%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 728.38 K $837.64 K   26.38% 1.16%
HEALTHINVEST PARTNERS AB 02/06/2026 617.25 K $709.83 K   100.00% 0.99%
BANK OF AMERICA CORP /DE/ 02/17/2026 587.85 K $676.03 K   -4.56% 0.94%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 577.21 K $664.21 K   6.01% 0.92%
LONGAEVA PARTNERS L.P. 02/17/2026 503.21 K $578.70 K   0.00% 0.80%
UBS GROUP AG 01/29/2026 392.77 K $451.68 K   5.09% 0.63%
MARSHALL WACE, LLP 02/13/2026 389.76 K $448.23 K   100.00% 0.62%
DECHENG CAPITAL LLC 02/12/2026 326.81 K $375.83 K   0.00% 0.52%
EXODUSPOINT CAPITAL MANAGEMENT, LP 02/17/2026 317.77 K $365.43 K   100.00% 0.51%
XTX TOPCO LTD 02/17/2026 289.03 K $332.39 K   1,533.05% 0.46%
CITADEL ADVISORS LLC 02/17/2026 243.59 K $280.13 K   -27.80% 0.39%
STATE STREET CORP 02/13/2026 241.64 K $277.88 K   19.59% 0.39%
POINT72 ASSET MANAGEMENT, L.P. 02/17/2026 188.14 K $216.36 K   100.00% 0.30%
GRAHAM CAPITAL MANAGEMENT, L.P. 02/17/2026 183.94 K $211.53 K   100.00% 0.29%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 180.30 K $207.35 K   738.60% 0.29%
BANK OF NEW YORK MELLON CORP 02/10/2026 165.04 K $189.80 K   0.00% 0.26%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 145.81 K $167.69 K   373.30% 0.23%
NEWEDGE WEALTH, LLC 02/03/2026 116.01 K $133.41 K   0.00% 0.19%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 108.41 K $124.68 K   -21.17% 0.17%
TWO SIGMA INVESTMENTS, LP 02/17/2026 105.53 K $121.36 K   126.94% 0.17%
NORTHERN TRUST CORP 02/17/2026 101.95 K $117.24 K   1.17% 0.16%
QUADRATURE CAPITAL LTD 02/17/2026 100.54 K $115.62 K   100.00% 0.16%
MORGAN STANLEY 02/13/2026 89.22 K $102.61 K   -16.31% 0.14%
GOLDMAN SACHS GROUP INC 03/25/2026 86.15 K $99.07 K   -31.33% 0.14%
CITADEL ADVISORS LLC 02/17/2026 75.50 K $86.83 K   100.00% 0.12%
TORONTO DOMINION BANK 02/17/2026 75.00 K $86.25 K   100.00% 0.12%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/17/2026 72.70 K $83.61 K   -5.22% 0.12%
OMERS ADMINISTRATION CORP 02/13/2026 67.00 K $77.05 K   100.00% 0.11%
CABLE CAR CAPITAL LLC 02/17/2026 61.61 K $70.85 K   0.00% 0.10%
BARCLAYS PLC 02/13/2026 60.39 K $69.44 K   1,939.34% 0.10%
CITADEL ADVISORS LLC 02/17/2026 59.10 K $67.97 K   100.00% 0.09%
ROYAL BANK OF CANADA 02/17/2026 55.55 K $64.00 K   -28.76% 0.09%
03/23/2026 53.00 K $60.95 K   100.00% 0.08%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 50.07 K $57.58 K   37.11% 0.08%
UNIVERSITY OF CHICAGO 02/06/2026 48.73 K $56.04 K   0.00% 0.08%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/13/2026 40.00 K $46.00 K   -27.27% 0.06%
COMMONWEALTH EQUITY SERVICES, LLC 02/12/2026 39.76 K $45.72 K   -34.99% 0.06%
HRT FINANCIAL LP 02/12/2026 39.65 K $45.00 K   157.49% 0.06%
LPL FINANCIAL LLC 02/11/2026 35.10 K $40.37 K   150.69% 0.06%
AMERICAN CENTURY COMPANIES INC 02/13/2026 31.94 K $36.73 K   100.00% 0.05%
LIGHTHOUSE INVESTMENT PARTNERS, LLC 02/17/2026 28.86 K $33.19 K   100.00% 0.05%

Pyxis Oncology Inc institutional Ownership - FAQ's

During the previous two years, 103 institutional investors and hedge funds held shares of Pyxis Oncology Inc. The most heavily invested institutionals were:

UBS Group AG: 254,124

Bank of New York Mellon Corp: 133,996

COMMONWEALTH EQUITY SERVICES, LLC: 34,755

China Universal Asset Management Co., Ltd.: 11,049

Winthrop Capital Management, LLC: 6,000

Mirae Asset Global Investments Co., Ltd.: 3,248

48.27% of Pyxis Oncology Inc stock is owned by institutional investors.

Institutional investors have bought a total of 30.38 M shares in the last 24 months. This purchase volume represents approximately $45.57 M in transactions.